- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03137589
Telemedical, Intersectoral Network as New Digital Health Structure to Measurably Improve the Local Health Care (TELnet@NRW)
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
In future time the number of old people will significantly increase in Germany because of the demographic change taking place. The health care of the large number of old people will probably lead to a lack of physicians and an inefficient health care system. One strategy to tackle the problem could be telemedicine. Telemedicine makes it possible to provide know-ledge from experts to local hospitals and practices which otherwise need to send patients with serious and complex diseases to specialized trans-regional health centers. In this multicenter, prospective, non-interventional study hospitals and practices in NRW are supplied via a telematics platform with expert know-ledge from the university hospitals RWTH Aachen and Münster. The communication occurs via highly encrypted audio/video conference systems and a certified data exchange platform "Fallakte+".
In total 40.000 outpatient and stationary patients should be treated with telemedical support. Registered doctors will be involved in already existing practice networks to evaluate the potential for transfer and to ensure the sharing of know-ledge beyond the borders of individual sectors. The aim of the study is to improve the treatment quality of regional hospitals and practices and to increase the efficiency of the care of relevant patient cohort in the field of infectiology and intensive care with the main focus sepsis as those patient groups especially often require professional expertise for a successful therapy.
In the beginning of the study participating hospitals and practices are randomly distributed into four clusters (cluster randomization). The different clusters all start with the control phase but enter into the intervention phase at different times (stepped-wedge design). During the control phase data of patients with infection and intensive care patients routinely treated without the support of telemedicine are documented and the patients are asked to complete a questionnaire regarding health-related quality of life (SF36) directly after treatment and at two time points in the follow-up. The collected data will be later compared to data obtained in the same way from patients treated with telemedical support and evaluated regarding differences in the quality of treatment, therapeutic process and the satisfaction of the patients with telemedicine.
If the study shows that the treatment quality and therapeutic process of patients with infectious diseases or need for intensive care is improved by telemedicine, the telematics platform can be expanded and used by other specialized fields and users in future time.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Münster, Niemcy
- University Hospital Münster
-
-
NRW
-
Aachen, NRW, Niemcy, 52074
- University Hospital RWTH Aachen
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- majority
- written informed consent
- infectiological and/or intensive care treatment
Exclusion Criteria:
- minority
- absence of written informed consent in the case of non-acute life-threatening disease
- persons who have a dependency or employment relationship with the sponsor or investigator
- persons who are sheltered in an institution upon court or administrative order
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Diagnostyczny
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Brak interwencji: Control
Patients of this group are routinely treated without telemedical support.
|
|
Aktywny komparator: Telemedical support
Patients of this group are routinely treated with telemedical support.
|
Participating sites will be advised by telemedicine support.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Improvement of treatment quality
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
The level of implementation of the 10 recommendations of the German Society of Infectious Diseases (Deutsche Gesellschaft für Infektiologie, DGI) within the framework of the Initiative "Decide wisely" ("Klug entscheiden").
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Rate of sepsis diagnosis
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Rate of sepsis diagnosis
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Rate of ARDS Diagnosis
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Rate of ARDS Diagnosis
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Sepsis therapy in compliance with guidelines
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Sepsis therapy in compliance with guidelines through for instance timely administration of antibiotics within 3 h and reduction of sepsis mortality.
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Rate of ARDS therapy according to guidelines
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Measured against the evident ventilation targets, Ventilation with low ventilation volumes and low peak pressures: with controlled ventilation: Breath volume of 6 ml/kg calculated Body ideal weight, PEEP setting in proportion with the necessary FiO2, plateau pressure < 30 cm H2O |
through study completion, an average of 30 days up to a maximum of 1 year
|
Rate of inadequate antibiotic therapies
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Measured by the Percentage of postoperatively continued perioperative Antibiotic prophylaxis
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Rate of patients with dialysis
Ramy czasowe: At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year
|
Rate of patients with dialysis requiring Kidney insufficiency in discharge from the Intensive care
|
At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year
|
Rate of transfer transport
Ramy czasowe: At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year
|
Rate of transfer transport
|
At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year
|
Health-related quality of life (SF36-Questionnaire)
Ramy czasowe: At discharge from Intensive Care Unit (through study completion; an average of 30 days up to a maximum of 1 year), through study completion, an average of 12 months and 24 months after discharge of ICU
|
Clinical studies 36-item Medical Outcomes Study Short-Form General Health Survey An instrument used to assess multidimensional health-related QOL, which measures 8 health related parameters: physical function, social function, physical role, emotional role, mental health, energy, pain, general health perceptions; each parameter is scored from 0 to 100 Managed care 36-Item Short-Form Functional and Perceived Health Status Survey A questionnaire which measures health status; the SF-36 also includes a list of 18 self-reported chronic conditions
|
At discharge from Intensive Care Unit (through study completion; an average of 30 days up to a maximum of 1 year), through study completion, an average of 12 months and 24 months after discharge of ICU
|
Rate of non-diagnosed sepsis
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Defined as no filled out sepsis bundle despite presence of sepsis symptoms
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Sepsis mortality rate
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Sepsis mortality rate
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Hospital mortality rate
Ramy czasowe: through study completion, an average of 30 days up to a maximum of 1 year
|
Hospital mortality rate
|
through study completion, an average of 30 days up to a maximum of 1 year
|
Length of stay in intensive care unit
Ramy czasowe: At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year
|
Length of stay in intensive care unit measured in hours
|
At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year
|
Hospital stay
Ramy czasowe: At discharge from Hospital; after an average of 30 days up to a maximum of 1 year
|
Hospital stay measured in days
|
At discharge from Hospital; after an average of 30 days up to a maximum of 1 year
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Gernot Marx, Univ.-Prof. Dr. med., Clinic for Operative Intensive Care and Intermediate Care, University Hospital RWTH Aachen
Publikacje i pomocne linki
Publikacje ogólne
- Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007 Apr;33(4):606-18. doi: 10.1007/s00134-006-0517-7. Epub 2007 Feb 24.
- Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, Gastmeier P, Gerlach H, Grundling M, John S, Kern W, Kreymann G, Kruger W, Kujath P, Marggraf G, Martin J, Mayer K, Meier-Hellmann A, Oppert M, Putensen C, Quintel M, Ragaller M, Rossaint R, Seifert H, Spies C, Stuber F, Weiler N, Weimann A, Werdan K, Welte T; German Sepsis Society; German Interdisciplinary Association of Intensive Care and Emergency Medicine. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci. 2010 Jun 28;8:Doc14. doi: 10.3205/000103.
- Laxminarayan R, Bhutta Z, Duse A, Jenkins P, O'Brien T, Okeke IN, Pablo-Mendez A, Klugman KP. Drug Resistance. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006. Chapter 55. Available from http://www.ncbi.nlm.nih.gov/books/NBK11774/
- Marx G, Greiner W, Juhra C, Elkenkamp S, Gensorowsky D, Lemmen S, Englbrecht J, Dohmen S, Gottschalk A, Haverkamp M, Hempen A, Flugel-Bleienheuft C, Bause D, Schulze-Steinen H, Rademacher S, Kistermann J, Hoch S, Beckmann HJ, Lanckohr C, Lowitsch V, Peine A, Juzek-Kuepper F, Benstoem C, Sperling K, Deisz R. An Innovative Telemedical Network to Improve Infectious Disease Management in Critically Ill Patients and Outpatients (TELnet@NRW): Stepped-Wedge Cluster Randomized Controlled Trial. J Med Internet Res. 2022 Mar 2;24(3):e34098. doi: 10.2196/34098.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- 16-162
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Telemedical support
-
Medical University of South CarolinaNational Center for Advancing Translational Sciences (NCATS)ZakończonyChoroba Alzheimera | Łagodne upośledzenie funkcji poznawczychStany Zjednoczone
-
Karolinska InstitutetRekrutacyjnyOstra niewydolność oddechowaSzwecja
-
Washington University School of MedicineNational Institutes of Health (NIH)Rekrutacyjny
-
VA Office of Research and DevelopmentRekrutacyjnyMieszkania | Wykorzystanie usług opieki doraźnej | Stan zdrowia psychicznego | Stan zdrowia fizycznegoStany Zjednoczone
-
Teachers College, Columbia UniversityColumbia UniversityRekrutacyjnyPorażenie mózgoweStany Zjednoczone
-
Dana-Farber Cancer InstituteWycofaneGlejak niskiego stopnia | Przetrwanie | Obciążenie związane z opiekąStany Zjednoczone
-
Butler HospitalNational Institute of Mental Health (NIMH)ZakończonyZaburzenie psychotyczneStany Zjednoczone
-
Ada Health GmbHMuhimbili University of Health and Allied SciencesAktywny, nie rekrutującyStany neurologiczne | Warunki zdrowia psychicznego | Ból brzucha/Problemy żołądkowo-jelitowe | Warunki dolnego układu oddechowego | Choroby górnych dróg oddechowych | Warunki okulistyczne | Warunki ortopedyczne | Warunki układu sercowo-naczyniowego | Warunki układu moczowo-płciowego | Warunki laryngologiczne | Warunki... i inne warunkiTanzania
-
University of British ColumbiaBrainTrust Canada; ABI Wellness; The Kelowna Women's Shelter; Nanaimo Brain Injury...RekrutacyjnyŁagodne urazowe uszkodzenie mózguKanada
-
Butler HospitalNational Institute of Mental Health (NIMH)ZakończonyZaburzenia psychotyczneStany Zjednoczone